Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
BioTech
Medical Devices
About Investor
Beryl Cummings is Head of Genetics and a Program Team Lead at Marea Therapeutics. She previously worked as a Senior Associate at Third Rock Ventures, where she worked on building new biotech companies. She completed a PhD in human genetics at Harvard Medical School and Broad Institute and was part of the Genome Aggregation Database (gnomAD) team. After her training, she was an early hire into the human genetics team at Maze Therapeutics.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.